Cover Image

HBA1C Levels, Lipid Profile and Thyroid Profile in Patients Admitted with Severe Hypoglycemia in Type 2 Diabetes Mellitus

Sreenivasa rao sudulagunta, Shiva Kumar B.R., Mahesh Babu Sodalagunta, Hadi Khorram, Mona Sepehrar, Zahra Noroozpour


Objective: We studied the association between HbA1c level, Lipid profile and Thyroid profile in patients admitted with hypoglycemia in type 2 diabetes mellitus. Materials and methods: Patients admitted with severe hypoglycemia (<50mg/dl) are included in this observational study from 4 hospitals from January 2013 till January 2015. HBA1C, Lipid profile and Thyroid profile recorded during admission are the points of interest in this study. Demographic and clinical variables were recorded to evaluate the relative risk (RR) of severe hypoglycemia across HbA1c levels. We also studied comorbidities associated with DM. Results: Among 1200 patients enrolled, mean age was 58.6±11.7 years. 83% of patients were above 50 years of age of which 50% were in 50-59 years age group. Mean Glycated hemoglobin was 8.3±2.09. Patients admitted with hypoglycemia constitute 118(9.83%), 64(5.33%), 200 (16.6%), 624(52%) and 194(16.16%) in HbA1c categories <6, 6–6.9, 7–7.9, 8–8.9, and >9% which is statistically significant (P value<0.01). Abnormal lipid profile was found in 96.5 %( 1158) of the study population and abnormal Thyroid profile in 11.6%. Conclusions: Hypoglycemia can occur at any level of glycated Hemoglobin but high risk is found with HBA1c of <6% and >8%. Elderly population should not be subjected for stricter control of blood sugars which can do more harm than good. Patients with mean duration of diabetes more than 10 years are at higher risk of recurrent hypoglycemia.


Glycated Hemoglobin (HBA1c); Thyroid profile; Chronic Kidney disease (CKD); Ischemic Heart disease (IHD); Hypoglycemia; Dyslipidemia

Full Text:



Stedman, Thomas Lathrop (December 2005) [1911]. "Stedman's Medical Dictionary" (28th ed.). Baltimore: Lippincott Williams & Wilkins. p. 2100.

Hill NR, Thompson B, Bruce J, et al. Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus. Diabet Med. 2009, 26(7):740-743

Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. Aug 5 2009

Prolonged Nocturnal Hypoglycemia Is Common During 12 Months Of Continuous Glucose Monitoring In Children And Adults With Type 1 Diabetes. Diabetes Care. Mar 3 2010

Cryer, Philip E. Hypoglycemia: pathophysiology, diagnosis, and treatment. Oxford University Press. 1997

Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999, 16 (6): 466–71.

Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565-1572

Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Health, Aging, and Body Composition Study. Diabetes-related complications,glycemic control, and falls in older adults. Diabetes Care. 2008, 31:391-396

Johnston SS, Conner C, AagrenM, Ruiz K, Bouchard J. Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes. Diabetes Obes Metab. 2012,14:634-643

Johnston SS, Conner C, Aagren M, Smith DM, Bouchard J, Brett J. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2011, 34:1164-1170

Green AJ, Fox KM, Grandy S; SHIELD Study Group. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012, 96:313-318

McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012, 35:1897-1901

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progressions of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329:977-986

Miller ME, Bonds DE, Gerstein HC, et al.; ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010, 340:b5444

Mooradian, AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 5: 150-159

Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract. 2010, 64(8):1130-1139

Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nature Clinical Practice Endocrinology and Metabolism. 2007, 3(9):632-640

Piette JD. Patient education via automated calls: A study of English and Spanish speakers with diabetes. Am J Prev Med. 1999, 17:13138-41

HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study Diabetes Care November 2013 36:11 3535-3542; published ahead of print July 30, 2013, doi:10.2337/dc13-0610.

One adult in ten will have diabetes by 2030. International Diabetes Federation. November 14, 2011. Available at

American Geriatrics Society. Five things physicians and patients should question: Choosing Wisely: an initiative of the American Board of Internal Medicine. Accessed August 5, 2013


  • There are currently no refbacks.

AJDOM (ISSN 2689-1883)Copyright © 2012-2020. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States